Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Osheroff

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Pharmacology & Therapeutics|January 1, 1989
Biochemical basis for the interactions of type I and type II topoisomerases with DNAN Osheroff
The Journal of Biological Chemistry|July 25, 1986
Eukaryotic topoisomerase II. Characterization of enzyme turnoverN Osheroff
Biochimica Et Biophysica Acta|December 29, 1998
DNA topoisomerasesN Osheroff
Biochemistry|October 6, 1987
Role of the divalent cation in topoisomerase II mediated reactionsN Osheroff
Biochemistry|July 25, 1989
Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposideN Osheroff
Nucleic Acids Research|April 11, 2000
Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesionsM Sabourin, N Osheroff
The Journal of Biological Chemistry|July 15, 1989
Regulation of casein kinase II activity by epidermal growth factor in human A-431 carcinoma cellsP Ackerman, N Osheroff
The EMBO Journal|December 1, 1990
Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossoversE L Zechiedrich, N Osheroff
The Journal of Biological Chemistry|July 4, 1998
Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavageJ M Fortune, N Osheroff
Current Pharmaceutical Design|March 20, 2001
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. HydeV E Anderson, N Osheroff
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Pharmacology & Therapeutics|January 1, 1989
Biochemical basis for the interactions of type I and type II topoisomerases with DNAN Osheroff
The Journal of Biological Chemistry|July 25, 1986
Eukaryotic topoisomerase II. Characterization of enzyme turnoverN Osheroff
Biochimica Et Biophysica Acta|December 29, 1998
DNA topoisomerasesN Osheroff
Biochemistry|October 6, 1987
Role of the divalent cation in topoisomerase II mediated reactionsN Osheroff
Biochemistry|July 25, 1989
Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposideN Osheroff
Nucleic Acids Research|April 11, 2000
Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesionsM Sabourin, N Osheroff
The Journal of Biological Chemistry|July 15, 1989
Regulation of casein kinase II activity by epidermal growth factor in human A-431 carcinoma cellsP Ackerman, N Osheroff
The EMBO Journal|December 1, 1990
Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossoversE L Zechiedrich, N Osheroff
The Journal of Biological Chemistry|July 4, 1998
Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavageJ M Fortune, N Osheroff
Current Pharmaceutical Design|March 20, 2001
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. HydeV E Anderson, N Osheroff
Pageof 11